<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30242840</article-id>
<article-id pub-id-type="pmc">6332743</article-id>
<article-id pub-id-type="doi">10.1113/JP276796</article-id>
<article-id pub-id-type="publisher-id">TJP13254</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Renal</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>NHA2 promotes cyst development in an <italic>in vitro</italic> model of polycystic kidney disease</article-title>
<alt-title alt-title-type="left-running-head">H. Prasad and others</alt-title>
<alt-title alt-title-type="right-running-head">NHA2 regulates cyst size in polycystic kidney disease</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp13254-cr-0001">
<name>
<surname>Prasad</surname>
<given-names>Hari</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0486-1919</contrib-id>
<xref ref-type="aff" rid="tjp13254-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13254-cr-0002">
<name>
<surname>Dang</surname>
<given-names>Donna K.</given-names>
</name>
<xref ref-type="aff" rid="tjp13254-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="d35e66">*</xref>
</contrib>
<contrib contrib-type="author" id="tjp13254-cr-0003">
<name>
<surname>Kondapalli</surname>
<given-names>Kalyan C.</given-names>
</name>
<xref ref-type="aff" rid="tjp13254-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13254-cr-0004">
<name>
<surname>Natarajan</surname>
<given-names>Niranjana</given-names>
</name>
<xref ref-type="aff" rid="tjp13254-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13254-cr-0005">
<name>
<surname>Cebotaru</surname>
<given-names>Valeriu</given-names>
</name>
<xref ref-type="aff" rid="tjp13254-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="tjp13254-cr-0006">
<name>
<surname>Rao</surname>
<given-names>Rajini</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1833-5971</contrib-id>
<address>
<email>rrao@jhmi.edu</email>
</address>
<xref ref-type="aff" rid="tjp13254-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="tjp13254-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Physiology</named-content>
<institution>Johns Hopkins University School of Medicine</institution>
<named-content content-type="city">Baltimore</named-content>
<named-content content-type="country-part">MD</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp13254-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>University of Maryland School of Medicine</institution>
<named-content content-type="city">Baltimore</named-content>
<named-content content-type="country-part">MD</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> R. Rao: Department of Physiology, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Baltimore, MD 21205, USA. Email: <email>rrao@jhmi.edu</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>597</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2019.597.issue-2</issue-id>
<fpage>499</fpage>
<lpage>519</lpage>
<history>
<date date-type="received">
<day>07</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2019 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-597-499.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="tjp13254-sec-0010">
<title>Key points</title>
<p>
<list id="tjp13254-list-0001" list-type="bullet"><list-item><p>Significant and selective up‐regulation of the Na<sup>+</sup>/H<sup>+</sup> exchanger NHA2 (<italic>SLC9B2</italic>) was observed in cysts of patients with autosomal dominant polycystic kidney disease.</p></list-item><list-item><p>Using the MDCK cell model of cystogenesis, it was found that NHA2 increases cyst size. Silencing or pharmacological inhibition of NHA2 inhibits cyst formation <italic>in vitro</italic>.</p></list-item><list-item><p>Polycystin‐1 represses NHA2 expression via Ca<sup>2+</sup>/NFAT signalling whereas the dominant negative membrane‐anchored C‐terminal fragment (PC1‐MAT) increased NHA2 levels.</p></list-item><list-item><p>Drugs (caffeine, theophylline) and hormones (vasopressin, aldosterone) known to exacerbate cysts elicit NHA2 expression.</p></list-item><list-item><p>Taken together, the findings reveal NHA2 as a potential new player in salt and water homeostasis in the kidney and in the pathogenesis of polycystic kidney disease.</p></list-item></list>
</p>
</sec>
<sec id="tjp13254-sec-0020">
<title>Abstract</title>
<p>Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in <italic>PKD1</italic> and <italic>PKD2</italic> encoding polycystin‐1 (PC1) and polycystin‐2 (PC2), respectively. The molecular pathways linking polycystins to cyst development in ADPKD are still unclear. Intracystic fluid secretion via ion transporters and channels plays a crucial role in cyst expansion in ADPKD. Unexpectedly, we observed significant and selective up‐regulation of NHA2, a member of the <italic>SLC9B</italic> family of Na<sup>+</sup>/H<sup>+</sup> exchangers, that correlated with cyst size and disease severity in ADPKD patients. Using three‐dimensional cultures of MDCK cells to model cystogenesis <italic>in vitro</italic>, we showed that ectopic expression of NHA2 is causal to increased cyst size. Induction of PC1 in MDCK cells inhibited NHA2 expression with concordant inhibition of Ca<sup>2+</sup> influx through store‐dependent and ‐independent pathways, whereas reciprocal activation of Ca<sup>2+</sup> influx by the dominant negative membrane‐anchored C‐terminal tail fragment of PC1 elevated NHA2. We showed that NHA2 is a target of Ca<sup>2+</sup>/NFAT signalling and is transcriptionally induced by methylxanthine drugs such as caffeine and theophylline, which are contraindicated in ADPKD patients. Finally, we observed robust induction of NHA2 by vasopressin, which is physiologically consistent with increased levels of circulating vasopressin and up‐regulation of vasopressin V2 receptors in ADPKD. Our findings have mechanistic implications on the emerging use of vasopressin V2 receptor antagonists such as tolvaptan as safe and effective therapy for polycystic kidney disease and reveal a potential new regulator of transepithelial salt and water transport in the kidney.</p>
</sec>
</abstract>
<abstract abstract-type="toc" id="d35e317">
<title>Key points</title>
<p>
<list id="tjp13254-list-0002" list-type="bullet"><list-item><p>Significant and selective up‐regulation of the Na<sup>+</sup>/H<sup>+</sup> exchanger NHA2 (<italic>SLC9B2</italic>) was observed in cysts of patients with autosomal dominant polycystic kidney disease.</p></list-item><list-item><p>Using the MDCK cell model of cystogenesis, it was found that NHA2 increases cyst size. Silencing or pharmacological inhibition of NHA2 inhibits cyst formation <italic>in vitro</italic>.</p></list-item><list-item><p>Polycystin‐1 represses NHA2 expression via Ca<sup>2+</sup>/NFAT signalling whereas the dominant negative membrane‐anchored C‐terminal fragment (PC1‐MAT) increased NHA2 levels.</p></list-item><list-item><p>Drugs (caffeine, theophylline) and hormones (vasopressin, aldosterone) known to exacerbate cysts elicit NHA2 expression.</p></list-item><list-item><p>Taken together, the findings reveal NHA2 as a potential new player in salt and water homeostasis in the kidney and in the pathogenesis of polycystic kidney disease.</p></list-item></list>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="tjp13254-kwd-0001">Na<sup>+</sup>/H<sup>+</sup> exchanger</kwd>
<kwd id="tjp13254-kwd-0002">polycystin</kwd>
<kwd id="tjp13254-kwd-0003">vasopressin</kwd>
<kwd id="tjp13254-kwd-0004">Ca<sup>2+</sup> signaling</kwd>
<kwd id="tjp13254-kwd-0005">NFAT</kwd>
</kwd-group>
<counts>
<fig-count count="10"></fig-count>
<table-count count="0"></table-count>
<page-count count="21"></page-count>
<word-count count="11899"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp13254</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 January 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.4 mode:remove_FC converted:15.01.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group>
<fn id="tjp13254-note-0001">
<p>Edited by: Peying Fong &amp; Dennis Brown</p>
</fn>
<fn id="tjp13254-note-0002">
<p>H. Prasad and D. K. Dang contributed equally.</p>
</fn>
<fn id="tjp13254-note-0003">
<p>Preprint publication: Prasad H, Dang DK, Kondapalli KC, Natarajan N, Cebotaru V &amp; Rao R (2018). NHA2 promotes cyst development in an in vitro model of polycystic kidney disease. <italic>bioRxiv</italic>. <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1101/364679">http://doi.org/10.1101/364679</ext-link>.</p>
</fn>
<fn id="tjp13254-note-0004">
<p>
<bold>Linked articles</bold>: This article is highlighted in a Perspectives article by Bevensee. To read this article, visit <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1113/JP276727">https://doi.org/10.1113/JP276727</ext-link>.</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>